| |
|
|
|
Viking Thera  
|
|
7.19 0.37 (0.05%) |
01-25 16:00 |
|
Open: |
6.86 |
Pre close: |
6.82 |
Target:
|
8.40 
|
|
High: |
7.195 |
Low: |
6.83 |
Resistance:
|
7.20
8.40
|
|
Volume: |
1,967,610 |
Market Cap: |
525M |
Support:
|
6.18
5.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.87
|
MACD |
MACD(12,26):
|
0.20 |
|
MA(20): |
6.36 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
6.16 |
Stochastic Oscillator |
%K(14,3):
|
88.66 |
|
MA(250): |
6.38 |
%D(3): |
84.69 |
|
Average Volume(K) |
3-Month: |
126859
|
52-Week |
High:
|
8.36 |
|
10-Days: |
117120 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
65.73 |
Change(%): |
10.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.500 |
Return on Equity (ttm) |
-13.4 |
Shares Out. (M) |
72.95 |
|
EPS Est. Current Year |
-0.830 |
Return on Assets (ttm) |
-9.1 |
Shares Float (M) |
57.16 |
|
EPS Est. Next Year |
-0.800 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.51 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
56.71 |
|
Forward EPS |
-0.360 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
8810 |
|
Book Value (p.s.) |
3.480 |
EBITDA (p.s.) |
0.000 |
P/E |
-14.38 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.03 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-22.25 |
P/CF |
-18.71 |
|
|
|
|
|
|
